IP Library Granted Patent US 7,157,276
Granted Patent B2
US 7,157,276 · App. 10/871,261 · Granted Jan 2, 2007

Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,157,276
App. No.
10/871,261
Granted
Jan 2, 2007
Kind
B2
Abstract

Methods for clarification of cell samples using centrifugation in combination with depth filtration.

Claims (19)

1. A method for clarification of an industrial scale cell sample comprising the steps of:

(a) centrifuging a cell sample using a gravitational force within a range of about 8,000×g to about 15,000×g and a Q/Σ ratio ranging between 0.9×10 −8 and 2.8×109 for industrial scale production of therapeutic proteins, whereby a solid phase comprising cells and debris is separated from a centrate; and

(b) applying the centrate to a depth filtration means.

2. The method of claim 1 , wherein the cell sample comprises bacterial cells.

3. The method of claim 1 , wherein the cell sample comprises mammalian cells.

4. The method of claim 3 , wherein the mammalian cells are CHO cells.

5. The method of claim 3 , wherein the mammalian cells are NSO cells.

6. The method of claim 1 , wherein the cell sample comprises a cell suspension, a cell slurry, or a cell culture.

7. The method of claim 1 , wherein the cell sample has a volume of at least about 2200 L.

8. The method of claim 1 , wherein the cell sample has a volume of at least about 15,000 L.

9. The method of claim 1 , wherein the cell sample further comprises an antifoam agent.

10. The method of claim 1 , wherein the centrifuging is performed using a gravitational force within the range of about 8,000×g to about 10,000×g.

11. The method of claim 1 , wherein the separation efficiency is at least about 95% following the centrifuging step.

12. The method of claim 1 , wherein the centrate is substantially free of cells and debris greater than about 2 μm.

13. The method of claim 1 , wherein the depth filtration means comprises one or more filters.

14. The method of claim 13 , wherein the depth filtration means of step (b) is selected from the group consisting of a depth filter and a polishing filter.

15. The method of claim 14 , wherein a final filter of the depth filtration means has a pore size of about 0.1 μm to about 0.2 μm.

16. The method of claim 15 , wherein the final filter has a pore size of at least about 0.2 μm.

17. The method of claim 15 , wherein the final filter has a pore size of at least about 0.1 μm.

Assignments (3)
CHANGE OF NAME Recorded Apr 30, 2015
From: BIOGEN IDEC INC.
To: BIOGEN INC.
Reel/Frame 035552/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2004
From: PHAM, CHRISTINE Y.
To: BIOGEN IDEC INC.
Reel/Frame 015338/0820 →
CHANGE OF NAME Recorded Aug 6, 2004
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 015044/0873 →